A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT07037901 · RECRUITING
Trial details
- NCT number
- NCT07037901
- Sponsor
- Inmagene LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-17
- Primary completion
- 2027-12-01
- Enrollment
- 405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.